|
Statement
| 1.Date of the shareholders' meeting resolution:2022/06/22
2.Name and title of the managerial officer with permission
to engage in competitive conduct:
Director HUNAG,CHANG-I
Director HUNAG,PO-WEN
Director HWANG,YIH-RAY
3.Items of competitive conduct in which the officer is
permitted to engage:
Director HUNAG,CHANG-I /Vice General Manager of Taiwan Ma Kuang
United Clinics of Traditional Chinese Medicine
Director HUNAG,PO-WEN /Director of Chi Fen Co., Ltd.
Director HWANG,YIH-RAY /Director of Chi Fen Co., Ltd.
4.Period of permission to engage in the competitive conduct:
For the duration of serving as a director of the Company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 209 of the
Company Act):
By the Article 209 of the Company Law,upon the approval of the
Shareholders' Meeting of the Company on June 22, 2022, the restriction
on the new part-time employment of the above directors shall be lifted
without prejudice to the interests of the Company.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the directors (if it is not the operator of
a mainland China enterprise, please enter "N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:None
11.If the directors have invested in the mainland China
enterprise, the monetary amount of the investment and
their shareholding ratio:N/A
12.Any other matters that need to be specified:None
|
